Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharm-Olam Appoints Robert Davie as CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Pharm-Olam Appoints Robert Davie as CEO

Succeeds David Grange, positioning organization for continued growth

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharm-Olam, a global midsized contract research organization (CRO), has named Robert Davie, Ph.D., as its new chief executive officer. Pharm-Olam provides full-service clinical development solutions for oncology-hematology, infectious disease, vaccines, and rare diseases.
 
Davie succeeds David Grange who has served as Pharm-Olam’s chief executive since April 2017. Grange will remain a director and vice chairman of the company’s board and will continue to support the organization and its work in U.S. government-funded research, which is an expanding area of Pharm-Olam’s business.
 
“Rob Davie is a respected leader who has worked within the CRO industry for over 25 years. We look forward to his leadership and knowledge supporting the continued growth of Pharm-Olam,” said Zev Munk, founder and chairman of the board, Pharm-Olam. “We also extend our sincere thanks to David Grange for his leadership over the past two-and-a-half years, having transformed Pharm-Olam’s therapeutic focus while achieving record sales for 2018.”
 
Davie previously held critical roles within Covance, most recently as vice president and general manager of global clinical development.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters